Health

Charlotte's Web Ventures into FDA Approval for Autism Drug: A New Horizon in Botanical Therapies

Charlotte's Web Holdings, a leader in hemp extract wellness products, is advancing a novel botanical drug targeting Autism Spectrum Disorder (ASD) through the FDA approval process. Partnered with AJNA BioSciences and British American Tobacco, their joint venture, DeFloria LLC, reported successful Phase 1 trials for AJA001. This marks a significant step in integrating botanical-based therapies into pharmaceutical medicine, potentially opening new markets for both patients and shareholders.
Read More

The Latest